The field of regenerative aesthetics has evolved rapidly, with exosomes and polynucleotides (PNs) emerging as two of the most sought-after treatments for skin rejuvenation. Both harness the body's own biological processes to repair, regenerate, and revitalise tissue — but they work through fundamentally different mechanisms.
In this evidence-based guide, we break down the science behind each approach, compare their clinical applications, and help you determine which is best suited to your patients' needs.
What Are Exosomes?
Exosomes are extracellular vesicles (30–150 nm in diameter) secreted by cells as part of normal intercellular communication. In aesthetic medicine, exosomes derived from mesenchymal stem cells (MSCs) are of particular interest because they carry a potent cargo of:
- Growth factors — including EGF, FGF, VEGF, and TGF-β
- Cytokines and chemokines — modulating inflammation and immune response
- mRNA and microRNA — capable of reprogramming target cell behaviour
- Lipids and proteins — supporting membrane fusion and signal transduction
When applied topically or delivered via microneedling, exosomes are internalised by fibroblasts and keratinocytes, triggering cascades that promote collagen synthesis, angiogenesis, and cellular proliferation. Research published in the Journal of Extracellular Vesicles (2021) has demonstrated that MSC-derived exosomes can accelerate wound healing by up to 40% compared to controls.
What Are Polynucleotides?
Polynucleotides are long chains of nucleotides — the building blocks of DNA and RNA — typically sourced from salmon or trout sperm DNA through a highly purified extraction process. In clinical use, PN-based products (often branded as PDRN — polydeoxyribonucleotide) act as biostimulators that:
- Activate the A2A purinergic receptor — stimulating the salvage pathway for DNA repair
- Promote fibroblast proliferation — increasing collagen and elastin production
- Enhance tissue hydration — through their hygroscopic polymer structure
- Reduce inflammation — by modulating pro-inflammatory cytokines (IL-6, TNF-α)
Polynucleotides are typically administered via intradermal injection and have been used extensively in Korean and European aesthetic protocols since the early 2010s.
Head-to-Head Comparison
| Feature | Exosomes | Polynucleotides |
|---|---|---|
| Origin | Stem cell-derived vesicles | Purified salmon/trout DNA fragments |
| Primary mechanism | Intercellular signalling via growth factors & RNA | A2A receptor activation & DNA salvage pathway |
| Delivery method | Topical, microneedling, mesotherapy | Intradermal injection |
| Onset of results | 7–14 days (progressive over 4–8 weeks) | 2–4 weeks (progressive over 6–12 weeks) |
| Key benefits | Broad regenerative signalling, anti-inflammatory | Deep tissue hydration, biostimulation |
| Downtime | Minimal (redness for 24–48 hours) | Mild swelling and bruising (2–5 days) |
| Ideal candidates | Post-procedure recovery, photoageing, scarring | Dehydrated skin, fine lines, skin laxity |
| Sessions required | 3–6 sessions, 2–4 weeks apart | 3–4 sessions, 2–3 weeks apart |
When to Choose Exosomes
Exosomes are particularly advantageous when you need:
- Post-procedure healing acceleration — after laser resurfacing, microneedling, or chemical peels
- Comprehensive anti-ageing — addressing multiple pathways simultaneously
- Non-invasive application — topical delivery without needles
- Scar and wound management — leveraging their wound-healing properties
The Exo-Ox Regenerative Serum from Skymedic exemplifies this approach, delivering a concentrated exosome payload designed for professional clinical use.
When to Choose Polynucleotides
Polynucleotides may be the better choice for:
- Deep dermal hydration — their polymer structure retains moisture exceptionally well
- Biostimulation protocols — when the primary goal is collagen induction over months
- Injectable combination therapies — pairing with hyaluronic acid or skin boosters
- Patients seeking gradual improvement — with longer-lasting structural changes
Can You Combine Both?
Absolutely. Many forward-thinking practitioners are now using combination protocols that leverage the strengths of both modalities. A typical approach might involve:
- Polynucleotide injections for deep biostimulation and hydration
- Exosome application post-treatment to accelerate healing and amplify results
- Maintenance with topical exosome serums between sessions
This synergistic approach addresses both the structural (PN) and signalling (exosome) components of tissue regeneration.
The Skymedic Approach to Regenerative Skincare
At Skymedic, we specialise in advanced regenerative formulations backed by clinical research. Our Exosome Collection features pharmaceutical-grade products designed for professional protocols, including serums, masks, and post-procedure recovery systems.
Whether you're integrating exosomes into your practice for the first time or looking to optimise existing regenerative protocols, our team of specialists can help you select the right products for your clinical objectives.
Ready to explore regenerative skincare? Browse our full exosome range or contact our team for professional guidance.
